Reduced Plasma Cyclic GMP But Normal Renal Responses to Atrial Natriuretic Factor in Pre-Hypertension

References

• Cottier C, Matter L, Weidmann P, Shaw S, Gnädinger MP. Renal response to low-dose infusion of atrial natriuretic peptide in normal man. Kidney Int 1988; 34: 72–8, (Suppl 25)
   Web of Science ®Google Scholar
• Brown J, O'Flynn MA. Acute effects of physiological increments of α-atrial natriuretic peptide in normal man. Kidney Int 1989; 36: 645–52
   PubMed Web of Science ®Google Scholar
• Richards AM, Espiner EA, Ikram H, Yandle TG. Atrial natriuretic factor in hypertension: Bioactivity at normal plasma levels. Hypertension 1989; 14: 261–8
   PubMed Web of Science ®Google Scholar
• Lang RE, Unger T, Ganten D. Atrial natriuretic peptide: a new factor in blood pressure control. J Hypertens 1987; 5: 255–71
   PubMed Web of Science ®Google Scholar
• Weidmann P, Saxenhofer H, Ferrier C, Shaw SG. Atrial natriuretic peptide in man. Am J Nephrol 1988; 8: 1–14
   PubMed Web of Science ®Google Scholar
• Bianchi G, Ferrari P, Salvati P, Salardi S, Parenti P, Cusi D, Guidi E. A renal abnormality in the Milan Hypertensive strain of rats and humans pre-dispoed to essential hypertension. J Hypertens 1986; 33–6, (Suppl 3)
   Google Scholar
• Weder AB. Red-cell lithium-sodium countertransport and renal lithium clearance in hypertension. N Engl J Med 1986; 314: 198–201
   PubMed Web of Science ®Google Scholar
• Ferrier C, Weidmann P, Hollmann R, Dietler R, Shaw S. Impaired response of atrial natriuretic factor to high salt intake in persons prone to hypertension. N Engl J Med 1988; 319: 1223–4
   PubMed Web of Science ®Google Scholar
• Ferrari P, Weidmann P, Ferrier C, Dietler R, Holmann R, Piso RJ. Dysregulation of atrial natriuretic peptide in hypertension-prone men. J Clin Endocrinol Metab 1990; 71: 944–50
   PubMed Web of Science ®Google Scholar
• Hirata Y, Ganguli M, Tobian L, Iwai J. Dahl S rats have increased natriuretic factor in atria but are markedly hyporesponsive to it. Hypertension 1984; 6: 148–55, (Suppl 1)
   Web of Science ®Google Scholar
• Sterzel BR, Luft FC, Gao Y, Lang RE, Ruskoaho H, Ganten D. Atrial natriuretic factor in sodium-sensitive and sodium-resistant Dahl rats. J Hypertens 1987; 5: 17–24
   PubMed Web of Science ®Google Scholar
• Steele TH, Challoner-Hue L. Genetics and salt modulate responses to atrial natriuretic factor. Hypertension 1988; 11: 745–9
   PubMed Web of Science ®Google Scholar
• Fiscus RR, Rapoport RM, Waldman SA, Murad F. Atriopeptin II elevates cyclic GMP, activates cyclic GMP-dependent protein kinase and causes relaxation in rat thoracic aorta. Biochem Biophys Acta 1985; 846: 179–84
   PubMedGoogle Scholar
• Blaine EH, Seymour AA, Marsh EA, Napier MA. Effects of atrial natriuretic factor on renal function and cyclic GMP production. Fed Proc 1986; 45: 2122–7
   PubMedGoogle Scholar
• Reubi FC. Nierenkrankheiten Third ed. Hans Huber AG, Bern 1982; 98, 85
   Google Scholar
• Sealey JE, Gerten-Banes J, Laragh JH. The renin system: variations in man measured by radioimmunoassay or bioassay. Kidney Int 1972; 1: 240–53
   PubMed Web of Science ®Google Scholar
• Malvano R, Gandolfi C, Giannessi D, Giannotti P, Grosso P. Radioimmunoassay of aldosterone in crude plasma extracts. J Nucl Biol Med 1976; 20: 37–44
   PubMedGoogle Scholar
• Shaw SG, Weidmann P. Potential pitfalls in the radio-immuno-assay of physiological plasma levels of atrial natriuretic peptide. Z Kardiol 1988; 77: 26–30, (Suppl 2)
   PubMedGoogle Scholar
• Weidmann P, Matter DR, Matter EE, Gnädinger MP, Uehlinger DE, Shaw S. Glucocorticoid and miner-alocorticoid stimulation of atrial natriuretic peptide release in man. J Clin Endocrinol Metab 1988; 66: 1233–9
   PubMed Web of Science ®Google Scholar
• Uehlinger DE, Zaman T, Weidmann P, Shawe S, Gnädinger MP. Pressure-dependence of atrial natriuretic peptide during norepinephrine infusion. Hypertension 1987; 10: 249–53
   PubMed Web of Science ®Google Scholar
• Nakamura M, Hatori N, Nakamura A, Fine BP, Aviv A. Cytosolic Ca2+ attenuates ANF-induced cyclic GMP response in vascular smooth muscle cells. J Hypertens 1989; 7: 51–6
   PubMed Web of Science ®Google Scholar
• Cusson JR, Hamet P, Gutkowska J, Kuchel O, Genest J, Cantin M. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension. J Hypertens 1987; 5: 435–43
   PubMed Web of Science ®Google Scholar
• Weidmann P, Ferrari P, Allemann Y, Shaw SG. Developing essential hypertension: A syndrome of relative ANF deficiency?. Can J Physiol 1991; 69: 1582–91
   PubMed Web of Science ®Google Scholar
• Jin H, Chen YF, Yang RH, Meng QC, Oparil S. Impaired release of atrial natriuretic factor in NaCl-loaded spontaneously hypertensive rats. Hypertension 1988; 11: 739–44
   PubMed Web of Science ®Google Scholar
• Onwochei MO, Rapp JP. Hyposecretion of atrial natriuretic factor by prehypertensive Dahl salt-sensitive rat. Hypertension 1989; 13: 440–8
   PubMed Web of Science ®Google Scholar
• Bates ER, Shenker J, Grekin RJ. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. Circulation 1986; 73: 1155–61
   PubMed Web of Science ®Google Scholar
• Curtis JJ, Luke RG, Dustan HP, Kashgarian M, Whelchel JD, Jones P. Remission of essential hypertension after renal transplantation. N Engl J Med 1983; 309: 1009–15
   PubMed Web of Science ®Google Scholar
• London GM, Safar ME, Safar AL, Simon AC. Blood pressure in the low-pressure system and cardiac performance in essential hypertension. J Hypertens 1985; 3: 331–42
   Web of Science ®Google Scholar
• Weidmann P, Hasler L, Gnädinger MP, Lang RE, Uehlinger DE, Shaw S. Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest 1986; 77: 734–42
   PubMed Web of Science ®Google Scholar
• Yamaji T, Ishibashi M, Takaku F. Atrial natriuretic factor in human blood. J Clin Invest 1985; 76: 1705–9
   PubMed Web of Science ®Google Scholar
• Haller BGD, Züst HJ, Shaw S, Gnädinger MP, Uehlinger DE, Weidmann P. Effects of posture and ageing on circulating atrial natriuretic peptide in man. J Hypertens 1987; 5: 551–6
   PubMed Web of Science ®Google Scholar
• Saxenhoffer H, Gnädinger MP, Weidmann P, Shaw S, Schohn D, Hess C. Plasma levels and dialysance of atrial natriuretic peptide in terminal renal Failure. Kidney Int 1987; 32: 554–61
   PubMedGoogle Scholar
• Marin-Grez M, Felming JT, Steinhaussen M. Atrial natriuretic peptide causes pre-glomerular vasodilation and post-glomerular vasoconstriction in rat kidney. Nature 1986; 324: 473–6
   PubMed Web of Science ®Google Scholar
• Cuneo RC, Espiner EA, Nicholls MG, Yandle TG, Livesey JH. Effect of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man. J Clin Endocrinol Metab 1986; 62: 1027–36
   PubMedGoogle Scholar
• Tobian L, Coffee K, McCrea P, Dahl LK. A comparison of the antihypertensive potency of kidneys from one strain of rats susceptible to salt hypertension and kidneys from another strain resistant to it. J Clin Invest 1966; 45: 1080
   Web of Science ®Google Scholar
• Bianchi G, Fox U, Di Francesco GF, Giovannetti AM, Paggetti D. Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med 1974; 47: 435–448
   PubMedGoogle Scholar
• Dahl LK. Excessive salt intake and hypertension. A dietary and genetic interplay. Brookhaven Lecture Ser 1962; 12: 22–35
   Google Scholar
• Bianchi G, Baer PG, Fox U, Guidi E. The role of the kidney in the rat with genetic hypertension. Postgrad Med J 1977; 53: 123–35, (Suppl 2)
   PubMed Web of Science ®Google Scholar